METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
Clinical trials for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radical surgery trial aims to extend control of spreading prostate cancer
Disease control Not yet recruitingThis study is for men whose prostate cancer has already spread to other parts of the body when first diagnosed. It tests whether adding surgery to remove the prostate (or radiation) to standard drug therapy helps control the cancer for a longer time without it getting worse, comp…
Matched conditions: METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
New prostate cancer drug combo tested in real patients across germany
Disease control Not yet recruitingThis study will observe 500 men in Germany with advanced prostate cancer that has spread but still responds to hormone therapy. Doctors will track how well the combination of darolutamide (a newer hormone-blocking drug) plus standard hormone therapy works in everyday medical prac…
Matched conditions: METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)
Sponsor: Bayer • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC